GHK-Cu Peptide: The Copper Peptide That Rewrites 4,000 Genes

GHK-Cu Peptide: The Copper Peptide That Rewrites 4,000 Genes

GHK-Cu (copper tripeptide-1) is a three-amino-acid copper peptide that Dr. Loren Pickart first isolated from human plasma in 1973, and laboratory gene data show it raising or lowering the activity of at least 4,000 human genes tied to collagen, antioxidant defense and tissue repair, according to Pickart, Vasquez-Soltero and Margolina (2015). In people, the evidence is strongest for topical skin creams in small placebo-controlled trials, and thin for injections, which the FDA flagged in 2023 for immunogenicity risk.

GHK-Cu is one of the most studied peptides in regenerative medicine, and one of the least hyped relative to its actual evidence base. Originally discovered in human plasma in 1973, this small copper-binding peptide plays a surprisingly large role in how your body repairs itself, controls inflammation, and maintains healthy tissue.

What makes GHK-Cu unusual is its scope. Most peptides target a single pathway or receptor. GHK-Cu changes the expression of more than 4,000 human genes in cell studies, shifting gene activity toward tissue repair and away from inflammation and tissue breakdown. That broad activity profile explains why it keeps showing up in research across so many different applications, from wound healing to hair regrowth to skin aging.

What Is GHK-Cu?

GHK-Cu stands for glycyl-L-histidyl-L-lysine copper(II). It is a tripeptide, meaning it consists of just three amino acids (glycine, histidine, and lysine) bound to a copper ion. Despite its small size, this molecule punches far above its molecular weight.

The same molecule appears under several names. Skin care labels use the INCI name copper tripeptide-1, researchers write GHK, Gly-His-Lys or GHK-Cu, and drug development papers use prezatide copper acetate. Products sold simply as "copper peptides" may contain GHK-Cu or a different copper complex.

Dr. Loren Pickart first identified GHK in 1973 while studying why liver tissue from younger donors stimulated more protein synthesis than tissue from older donors. He isolated a small peptide from human albumin that was responsible for the difference. When he added copper to GHK, forming GHK-Cu, the biological activity increased dramatically.¹

Your body produces GHK-Cu naturally. It circulates in your blood at concentrations around 200 ng/mL in your twenties, but levels decline significantly with age. By age 60, plasma concentrations drop to roughly 80 ng/mL. This decline mirrors many age-related changes in tissue repair capacity, wound healing speed, and skin quality, though whether the decline is a cause or consequence of aging remains an active area of research.²

GHK-Cu belongs to the wider family of therapeutic peptides used in regenerative and functional medicine, alongside BPC-157, TB-500 (thymosin beta-4) and KPV. Unlike most of them, it has a decades-long cosmetic track record, because copper tripeptide-1 has been sold in over-the-counter skin care since the 1990s.

How GHK-Cu Works: The Gene Expression Story

Most discussions of GHK-Cu focus on its role as a “collagen booster.” That undersells it considerably. In 2010, Hong and colleagues used the Broad Institute’s Connectivity Map, a library of gene expression responses to more than 1,300 compounds, and identified GHK as the compound most likely to reverse a gene signature linked to aggressive colon cancer.³ Pickart’s group then analyzed the same Connectivity Map data and reported that GHK changes the expression of at least 4,000 human genes.² The changes are not random. They follow a consistent pattern:

Genes That Get Turned Up

• Collagen synthesis genes (types I, III, and V), increasing structural protein production
• Elastin production genes, restoring skin elasticity
• Glycosaminoglycan synthesis genes (including decorin and hyaluronic acid), improving tissue hydration and structure
• Antioxidant defense genes (superoxide dismutase, glutathione), protecting cells from oxidative damage
• DNA repair genes, helping cells fix mutations and resist damage
• Stem cell recruitment genes, attracting repair cells to damaged tissue
• Nerve growth factor genes, supporting neural repair

Genes That Get Turned Down

• Pro-inflammatory cytokine genes (IL-6, TNF-alpha, TGF-beta overexpression), reducing chronic inflammation
• Matrix metalloproteinase (MMP) overexpression, slowing tissue breakdown
• Fibrinogen overproduction genes, reducing excessive scarring
• Pro-oxidant pathways, decreasing oxidative stress
• Insulin signaling disruption genes, with potential metabolic benefits

The net effect is a shift toward what researchers call a “remodeling” gene expression pattern. Tissue repair processes get amplified. Tissue destruction and chronic inflammation get dialed down. The size of these gene expression changes is large for a molecule this small, though no study has yet shown that the same pattern appears in human tissue after topical or injected use.⁴

Those numbers come with limits worth knowing. According to Pickart, Vasquez-Soltero and Margolina (2014) in BioMed Research International, the data cover 13,424 genes measured in two of the Connectivity Map’s five cell lines, treated with GHK at 1 micromolar, and 31.2% of those genes changed by 50% or more. That is a laboratory result in cultured cells, not a measurement of what happens inside a person using a serum or an injection.

Why the copper matters

GHK binds copper(II) very tightly and can deliver it to cells in a non-toxic form. Copper is a cofactor for lysyl oxidase, the enzyme that cross-links collagen and elastin, and for superoxide dismutase, one of the body’s main antioxidant enzymes. Pickart and colleagues (2015) report that GHK-Cu stimulates both the synthesis and the breakdown of collagen at very low concentrations of 1 to 10 nanomolar, which is why researchers describe it as a remodeling signal rather than a simple collagen booster.²

Skin Benefits: Where the Evidence Is Strongest

Skin is the organ with the most published research on GHK-Cu, and it is where the human evidence is most consistent. Most of these studies are small cosmetic trials in middle-aged women, and several were run or summarized by Pickart’s group, which has worked on commercial copper peptide products.

Collagen and Elastin Production

GHK-Cu stimulates collagen synthesis in dermal fibroblasts, the cells responsible for producing the structural proteins that keep skin firm. In a one-month study that applied creams to the thighs and measured collagen in skin biopsies, collagen increased in 70% of women treated with GHK-Cu, compared with 50% of women using a vitamin C cream and 40% using retinoic acid, according to the 2015 review by Pickart, Vasquez-Soltero and Margolina. GHK-Cu also stimulated elastin production, which is notoriously difficult to restore once lost.²

This matters because collagen and elastin decline begins in your late twenties and accelerates after age 40. Most topical products that claim to “boost collagen” have minimal evidence. GHK-Cu is one of the few cosmetic actives with biopsy data behind that claim, alongside prescription retinoids such as tretinoin.

Wrinkle Reduction and Skin Thickness

Clinical trials of topical GHK-Cu have shown measurable improvements in:

• Reduction in fine lines and wrinkle depth
• Increased skin thickness and density (measured by ultrasound)
• Improved skin firmness and elasticity
• Better skin clarity and reduced photodamage appearance

A 12-week facial study in 71 women with mild to advanced photoaging found that a GHK-Cu cream improved skin laxity, clarity and appearance, reduced fine lines and wrinkle depth, and increased skin density and thickness. A 12-week eye cream study in 41 women found GHK-Cu outperformed both a placebo and a vitamin K eye cream on lines, wrinkles and skin density, and a third 12-week study in 67 women aged 50 to 59 reported similar gains with twice-daily use, as summarized by Pickart and colleagues (2015).⁶

Dermatologists and aesthetic clinicians often pair GHK-Cu serums with procedures that create controlled skin injury, such as microneedling, fractional laser and chemical peels, on the reasoning that a repair signal is most useful when repair is under way. These combinations are common in practice but have not been tested in controlled trials. For a wider comparison of skin actives, see the overview of peptides for skin.

Wound Healing: From Lab to Clinic

GHK-Cu’s wound healing effects were among the first properties Dr. Pickart documented, and they remain some of the most robust findings in the literature. Most of that evidence comes from animal studies in rabbits, rats, mice, pigs and dogs, with fewer controlled trials in people.

GHK-Cu accelerates wound healing through multiple simultaneous mechanisms:

• Increased angiogenesis: promotes formation of new blood vessels to supply healing tissue
• Enhanced collagen deposition: accelerates the structural rebuilding phase of wound repair
• Nerve regeneration: supports nerve regrowth in the wound area, restoring sensation faster
• Anti-inflammatory effects: reduces excessive inflammation that can delay healing
• Stem cell attraction: recruits mesenchymal stem cells to the injury site
• Reduced scarring: modulates the balance between collagen deposition and breakdown to produce more normal tissue architecture rather than dense scar tissue

Studies in surgical wounds, diabetic ulcers, and burn injuries have shown accelerated healing with GHK-Cu treatment, mostly in animal models. In those models, GHK-Cu-treated wounds closed approximately 30% faster than untreated controls, with better cosmetic outcomes and less scarring.⁷

GHK-Cu was also studied for chronic wounds under the drug name prezatide copper acetate, but it is not an FDA-approved drug for any use. Chronic wounds, diabetic foot ulcers and serious burns need specialist wound care, and GHK-Cu is not a substitute for it.

Hair Growth: Promising but Early

GHK-Cu has shown effects on hair follicle biology that are relevant to hair loss treatment:

• It increases the size of hair follicles, which correlates with thicker hair shafts
• It stimulates hair follicle cells (dermal papilla cells) to proliferate
• It may extend the anagen (growth) phase of the hair cycle
• Its anti-inflammatory effects could benefit inflammatory types of hair loss

Some hair loss clinics now offer GHK-Cu injections (mesotherapy) into the scalp, often combined with microneedling. The rationale is sound based on the mechanism, but large-scale clinical trials specifically for hair regrowth are still limited. Most evidence comes from cell and organ culture work, such as the 2007 study by Pyo and colleagues on human hair follicles, plus case series and smaller studies. Patients with early-stage thinning appear to respond better than those with advanced hair loss.⁸

For androgenetic alopecia, the treatments with the deepest evidence are still FDA-approved minoxidil and finasteride, with platelet-rich plasma (PRP) and low-level laser as common in-office add-ons. GHK-Cu usually sits alongside these rather than replacing them. The hair loss treatment guide compares the options, and peptides for hair growth covers copper peptides next to other peptide approaches.

Anti-Inflammatory Effects

Chronic, low-grade inflammation (sometimes called “inflammaging”) drives many age-related diseases. GHK-Cu’s anti-inflammatory profile is notable because it works through gene expression changes rather than simply blocking a single inflammatory pathway.

In laboratory and animal studies, GHK-Cu has been shown to:

• Suppress IL-6 and TNF-alpha overexpression
• Reduce TGF-beta-driven fibrosis
• Block the release of oxidative and inflammatory damage signals in tissues
• Reset inflammatory gene expression toward patterns seen in younger, healthier tissue

This anti-inflammatory action is not as potent as pharmaceutical anti-inflammatory drugs for acute conditions. Its strength lies in modulating the chronic inflammatory signaling that contributes to tissue degeneration over time.⁹ In human dermal fibroblasts, copper complexes of GHK reduced IL-6 secretion triggered by TNF-alpha, according to Pickart and colleagues (2015), but no trial has tested GHK-Cu as a treatment for an inflammatory disease in people.

Topical vs. Injectable: Different Tools for Different Goals

GHK-Cu is available in two main forms, and choosing between them depends on what you are trying to accomplish. Topical copper tripeptide-1 is a cosmetic ingredient sold without a prescription, while injectable GHK-Cu is a compounded drug that a licensed prescriber orders from a pharmacy.

Topical Use

Topical GHK-Cu is the most accessible form and has the strongest clinical evidence for skin-specific outcomes. Look for products that list GHK-Cu (or “copper tripeptide-1”) in the active ingredients, ideally at concentrations of at least 0.01%. Higher concentrations (up to 1%) are available from specialty brands.

Application tips:

• Apply to clean, slightly damp skin for better absorption
• Use in the evening; GHK-Cu is stable but works well as part of a nighttime repair routine
• Can be combined with hyaluronic acid serums
• Avoid combining with strong acids (vitamin C at low pH, AHAs) in the same application, as acidic pH can disrupt the copper binding
• Results typically become noticeable after 8 to 12 weeks of consistent use

Can you use GHK-Cu with retinol or vitamin C?

GHK-Cu can be used in the same routine as retinol, tretinoin or vitamin C, but most clinicians suggest applying them at different times rather than layering them. Low-pH L-ascorbic acid serums and exfoliating acids can loosen the copper from the peptide, so a common pattern is vitamin C in the morning and GHK-Cu at night, or alternating nights with a retinoid.

Injectable Use

Subcutaneous GHK-Cu injections deliver the peptide systemically. This route is used when the goal extends beyond skin, such as injury recovery, systemic anti-inflammatory effects, or hair regrowth (scalp injections). Injectable GHK-Cu is typically obtained through compounding pharmacies and requires a prescription from a licensed provider.

Common injectable protocols range from 1 to 3 mg injected subcutaneously once daily, often as part of a broader peptide protocol. Some practitioners combine GHK-Cu with BPC-157 for enhanced tissue repair effects, though controlled human studies of this combination are limited.¹⁰ A three-peptide blend of GHK-Cu, BPC-157 and TB-500 is marketed as the GLOW peptide stack, and it carries the same evidence gap.

Dosing Guidelines

The doses below are protocols used in published cosmetic studies and in peptide clinics. Injectable and scalp doses have not been established by the FDA or by large human trials, so they describe common practice, not a validated standard.

How Long Does GHK-Cu Take to Work?

Topical GHK-Cu usually takes 8 to 12 weeks of daily use before changes in fine lines, firmness or skin density become visible. The facial and eye cream trials summarized by Pickart and colleagues (2015) all ran for 12 weeks, and the published topical studies used 8 to 16 weeks of consistent application. Collagen remodeling is slow, so four weeks is too early to judge a serum.

For injectable and scalp protocols, there are no controlled human timelines. Clinics commonly reassess after a 4 to 12 week course, and hair changes, if they occur, are typically judged over several months because the hair growth cycle is long.

Safety and Side Effects

GHK-Cu has a favorable safety record in published research on topical use. It is a naturally occurring molecule in the human body, and topical products have not raised significant safety signals in cosmetic studies. Injectable use is different: the FDA (2023) noted limited human data and a possible immunogenicity risk from aggregation and peptide-related impurities in compounded injections.

Topical side effects are rare and mild when they occur: occasional redness or irritation at application sites, typically in patients with very sensitive skin.

Injectable side effects reported by clinics are also generally mild:

• Injection site redness or mild swelling (common, temporary)
• Occasional mild headache
• Rare reports of mild nausea

Who should not use GHK-Cu?

People with Wilson’s disease or another copper metabolism disorder, people who are pregnant or breastfeeding, and anyone with active cancer should not start GHK-Cu without their specialist’s input. People with eczema, rosacea or very reactive skin can patch test a topical product on the inner arm for several days first. Injectable “research peptide” vials sold online are not made for human use, a sourcing problem covered in are peptides safe?

Is GHK-Cu FDA Approved? Regulatory Status in 2026

GHK-Cu is not FDA approved as a drug for any condition. Topical copper tripeptide-1 is sold legally as a cosmetic ingredient, which means it can be marketed for appearance but not to treat disease. Injectable GHK-Cu exists only as a compounded drug, and its status has shifted several times.

• September 29, 2023: The FDA added GHK-Cu for non-injectable routes to Category 1 and placed injectable GHK-Cu in Category 2 of its compounding bulk substance lists, the category for substances that may present significant safety risks, citing possible immunogenicity from aggregation and peptide-related impurities and limited human safety data.
• April 22, 2026: The nominations for GHK-Cu were withdrawn by the nominators, and the FDA moved injectable GHK-Cu to its list of substances nominated but withdrawn from Category 2, with the same safety note attached.
• May 14, 2026: According to the FDA’s 503A bulk drug substances list, GHK-Cu for non-injectable routes was returned to Category 1, the group still under evaluation, after one nominator clarified it had meant to withdraw only the injectable route, and the FDA said it intends to consult its Pharmacy Compounding Advisory Committee before the end of February 2027.

Removal from Category 2 is not an approval, and it does not place GHK-Cu on the 503A bulks list. Whether a pharmacy can compound injectable GHK-Cu depends on federal policy and on state boards of pharmacy, so ask any prescriber how the product is sourced. Similar questions apply to BPC-157 and other peptides that went through the same FDA review.

Evidence Summary by Application

No use of GHK-Cu has been tested in a large, independent, randomized trial. “Moderate” below means consistent laboratory, animal or small human data.

GHK-Cu vs. BPC-157 and TB-500

GHK-Cu, BPC-157 and TB-500 are the three peptides most often discussed for tissue repair, and clinics frequently combine them. They differ in origin, in the tissues they are studied for, and in how much human evidence exists. GHK-Cu is the only one of the three with published human cosmetic trials and an over-the-counter topical form.

How Much Does GHK-Cu Cost?

Quality topical GHK-Cu serums typically cost $30 to $120 per month, and injectable GHK-Cu through compounding pharmacies typically runs $150 to $400 per month, as shown in the topical versus injectable table above.

GHK-Cu is cash pay. Health insurance does not cover cosmetic copper peptide products, and it rarely covers compounded peptide injections, because none of them is an FDA-approved treatment.

Who Prescribes GHK-Cu and How to Find a Clinic

Injectable GHK-Cu is prescribed by licensed clinicians who run peptide or regenerative programs, most often functional and integrative medicine physicians, anti-aging and longevity clinics, dermatologists and aesthetic medicine practices, and in some states nurse practitioners or naturopathic doctors. A 503A compounding pharmacy prepares the injection for the individual patient. Topical serums need no prescriber, though a dermatologist can help fit them into a routine with retinoids or procedures.

You can browse peptide therapy clinics across the US in the Regenerated.com directory and compare what each lists. Listing order on Regenerated.com is not paid ranking. Featured slots are clearly labeled and capped, Verified means the clinic completed claim and credential checks rather than paying for placement, and the directory is free for patients. Inclusion in the directory is not an endorsement, and the guide to Featured, Verified and organic listings explains each label.

Before booking, ask a clinic these questions:

1. Which licensed clinician prescribes and supervises the GHK-Cu, and what is their training?
2. Which compounding pharmacy supplies it, and can they share a certificate of analysis for purity and sterility?
3. How does the clinic view the FDA’s 2023 safety note on injectable GHK-Cu, and how do they monitor for reactions?
4. What dose, route and course length do they propose, and how will they judge whether it is working?

How to Choose a Quality GHK-Cu Product

The GHK-Cu market ranges from well-formulated, evidence-based products to diluted, ineffective imitations. Here is what to look for:

• Active ingredient listing: Look for “copper tripeptide-1” or “GHK-Cu” explicitly listed in the ingredient panel, not just “copper peptides” (which could refer to many different molecules)
• Concentration disclosure: Reputable brands disclose their GHK-Cu concentration. Effective concentrations start at 0.01% for topical products
• pH formulation: GHK-Cu is most stable at pH 5.5 to 6.5. Products should not be highly acidic
• Packaging: Air-tight, opaque packaging protects the peptide from oxidation and light degradation. Avoid clear bottles or jar packaging
• Third-party testing: For injectable products, insist on certificates of analysis from the compounding pharmacy showing peptide purity (should be 98% or higher) and sterility testing

Frequently asked questions

What does GHK-Cu do for your skin?

GHK-Cu signals skin cells to remodel, increasing collagen, elastin and glycosaminoglycan production while calming inflammatory and tissue-breakdown genes. In small 12-week placebo-controlled trials summarized by Pickart and colleagues (2015), GHK-Cu creams increased skin density and thickness, reduced fine lines and wrinkle depth, and improved laxity and clarity in women with photoaged skin. A one-month biopsy study found collagen increased in 70% of women using GHK-Cu cream. The trials are small, so results vary.

Is GHK-Cu safe to inject?

Injectable GHK-Cu has limited human safety data. In 2023 the FDA placed compounded injectable GHK-Cu in its Category 2 safety list, citing possible immune reactions from aggregation and peptide-related impurities, and the nomination was withdrawn in April 2026 without the injectable form being approved. Clinics report mostly mild injection site redness or swelling. People with Wilson’s disease, active cancer, pregnancy or breastfeeding should avoid it, and any injection should come from a licensed pharmacy.

How long does it take for GHK-Cu to work?

Topical GHK-Cu usually needs 8 to 12 weeks of consistent daily use before changes in fine lines, firmness or skin density are visible, and the main facial trials ran for 12 weeks. Published topical studies used 8 to 16 weeks of application. Injectable and scalp protocols have no controlled human timelines, so clinics typically reassess after a 4 to 12 week course, and hair results are judged over several months.

Can I use GHK-Cu with retinol or vitamin C?

You can use GHK-Cu in the same skin care routine as retinol, tretinoin or vitamin C, but apply them at different times rather than layering them. Low-pH vitamin C serums and exfoliating acids such as AHAs can disrupt the copper binding that GHK-Cu depends on. A common approach is vitamin C in the morning and GHK-Cu at night, or alternating evenings between a retinoid and a copper peptide serum to limit irritation.

Is GHK-Cu FDA approved?

GHK-Cu is not FDA approved as a drug for any condition. Topical copper tripeptide-1 is legal to sell as a cosmetic ingredient, which allows appearance claims but not treatment claims. As of May 2026, the FDA lists GHK-Cu for non-injectable routes in compounding Category 1, still under evaluation, and injectable GHK-Cu on its withdrawn list. The FDA plans to consult its Pharmacy Compounding Advisory Committee on GHK-Cu before the end of February 2027.

Does GHK-Cu help with hair growth?

GHK-Cu may support hair growth, but the evidence is early. Cell and organ culture studies, including Pyo and colleagues (2007), found that copper peptides enlarged hair follicles and stimulated dermal papilla cells, and some clinics inject GHK-Cu into the scalp alongside microneedling. Large clinical trials for hair regrowth have not been published. People with early thinning appear to respond better, and GHK-Cu is usually added to minoxidil, finasteride or PRP rather than used alone.

Related Reading

• Peptide Therapy: The Complete Guide
• BPC-157: The Body Protection Compound Guide
• TB-500 (Thymosin Beta-4): Healing, Recovery, and What the Research Shows
• Exosome Therapy: What It Is, How It Works, and What the Evidence Says

Sources

1. Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008;19(8):969-988. doi:10.1163/156856208784909435 ↩
2. Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int. 2015;2015:648108. doi:10.1155/2015/648108 ↩
3. Hong Y, Downey T, Eu KW, Koh PK, Cheah PY. A “metastasis-prone” signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics. Clin Exp Metastasis. 2010;27(2):83-90. doi:10.1007/s10585-010-9305-4 ↩
4. Pickart L, Vasquez-Soltero JM, Margolina A. The effect of the human peptide GHK on gene expression relevant to nervous system function and cognitive decline. Brain Sci. 2017;7(2):20. doi:10.3390/brainsci7020020 ↩
5. Leyden JJ, Grove GL, Grove MJ, et al. Treatment of photodamaged facial skin with topical tretinoin. J Am Acad Dermatol. 1989;21(3):638-644.
6. Finkley MB, Appa Y, Bhandarkar S. Copper peptide and skin. In: Cosmeceuticals and Active Cosmetics. 2nd ed. CRC Press; 2005:549-563. ↩
7. Pickart L. The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health. Oxid Med Cell Longev. 2012;2012:324832. doi:10.1155/2012/324832 ↩
8. Pyo HK, Yoo HG, Won CH, et al. The effect of tripeptide-copper complex on human hair growth in vitro. Arch Pharm Res. 2007;30(7):834-839. doi:10.1007/BF02978833 ↩
9. Pickart L, Vasquez-Soltero JM, Margolina A. GHK-Cu may prevent oxidative stress in skin by regulating copper and modifying expression of numerous antioxidant genes. Cosmetics. 2015;2(3):236-247. doi:10.3390/cosmetics2030236 ↩
10. Campbell JD, Economou A, Dimopoulos G. Peptide combination therapy for tissue repair and regeneration: emerging evidence and clinical considerations. Regen Med. 2021;16(4):367-378. ↩